The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PSA flare in patients with metastatic castration-resistant prostate cancer undergoing 177Lu-PSMA treatment.
 
Haoran Li
No Relationships to Disclose
 
Elizabeth Marie Wulff-Burchfield
Stock and Other Ownership Interests - Immunomedics (I); Nektar (I)
Consulting or Advisory Role - Aptitude Health; Astellas Scientific and Medical Affairs Inc; AVEO; Bristol-Myers Squibb; Exelixis; Janssen Oncology; Targeted Oncology
Research Funding - Acerta Pharma/AstraZeneca (Inst); Pfizer
Patents, Royalties, Other Intellectual Property - Methods of use patent application has been submitted for the pharmaceutical product Osanetant, owned by Acer Therapeutics.
 
Saqib Abbasi
No Relationships to Disclose
 
Arshit Narang
No Relationships to Disclose
 
Emre Dal
No Relationships to Disclose
 
Joseph Donald
No Relationships to Disclose
 
Wendell Y Yap
No Relationships to Disclose
 
Xinglei Shen
No Relationships to Disclose
 
Ronald C. Chen
Employment - University of Kansas Medical Center
Consulting or Advisory Role - Abbvie; Accuray; Accuray; Astellas Pharma; Bayer; Blue Earth Diagnostics; Genentech; Janssen; Medivation/Astellas; Myovant Sciences; Pfizer
Research Funding - Accuray
Travel, Accommodations, Expenses - Reflexion Medical; Telix Pharmaceuticals
 
Rahul Atul Parikh
Stock and Other Ownership Interests - IBRX (I)
Patents, Royalties, Other Intellectual Property - Patents on DNA repair pathways in cancer. I do not receive any royalties for the same.